MICROBIAL PATTERNS AND DRUG SENSITIVITY TEST OF BACTERIAL AND FUNGAL INFECTION IN COVID-19 PATIENTS AT ADAM MALIK HOSPITAL, MEDAN, INDONESIA
DOI:
https://doi.org/10.21010/Ajid%20v19i1.5Keywords:
Antibiotics, antifungal, bacterial, fungal, COVID-19Abstract
Background: Bacteria or fungi in COVID-19 involves several mechanisms that can affect immune system and also can increase severity of symptoms. The incidence of bacterial or fungal infections is common in patients with viral respiratory tract infections but the prevalence of bacterial or fungal infections and drug sensitivity test pattern in COVID-19 patients is still not well understood. The aim of this study was to determine the bacterial or fungal infections and drug sensitivity test pattern in COVID-19 patients.
Methods: This is retrospective observational descriptive research with a cross-sectional design. The data was obtained from the COVID-19 patients medical records at Adam Malik Hospital, Medan, Indonesia
Result: A total population of 100 COVID-19 patients were included, with bacterial infections in 26 patients (26%), fungi in 5 patients (5%), bacteria and fungi in 5 patients (5%). The most common bacterial pathogen was Acinetobacter baumannii in 14 patients (45.1%), followed with Klebsiella pneumonia in 5 patients (16.1%), Pseudomonas aeruginosa in 5 patients (16.1%) and Escherichia coli in 3 patients (9.6%). The most sensitive antibiotic in Acinetobacter baumannii was Amikacin (57.14%), Trimethoprim/sulfamethoxazole (40.0%), Ampicillin sulbactam (28.6%), and Meropenem (21.4%). The most common fungal infection was Candida albicans in 5 patients (50.0%) and mostly sensitive to Fluconazole, Voriconazole, Caspofungin, Amphotericin B, Micafungin and Flucytosine (60.0%).
Conclusion: Bacterial and fungal infections can occur in COVID-19 patients. The data on pathogen patterns and sensitivity tests in this study can be the basis for administering antibiotics empiric in hospital for COVID-19 patients.
References
Bradley Langford, Miranda So, Sumit Ray Bardhan, Valerie Leung, Duncan Westwood, Derek MacFadden. (2020). Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Vol. 26, Clinical Microbiology and Infection. Elsevier B.V. p. 1622–9.
Case incidence [Internet]. Available from: https://covid19.go.id/peta-sebaran
Chloe Dimeglio, Jean-Michel Loubes, Jean-Michel Mansuy, and Jacques Izopet. (2021). Quantifying the impact of public health protection measures on the spread of SARS-CoV-2. Vol. 82, Journal of Infection. W.B. Saunders Ltd. p. 414–51.
Charles Feldman, and Ronald Anderson. (2021). The role of co-infections and secondary infections in patients with COVID-19. Pneumonia. 13(1).
Carolina Garcia-Vidal, Pere Barba, Montse Arnan, Asuncion Moreno, Isabel Ruiz-Camps, Carlota Gudiol, (2011). Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clinical Infectious Diseases. 15;53(6).
Carolina Garcia-Vidal, Gemma Sanjuan, Estela Moreno-García, Pedro Puerta-Alcalde, Nicole Garcia-Pouton, Mariana Chumbita; (2021). Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection. 1;27(1):83–8.
Chinmoy Sahu, Sweta Singh, Ashutosh Pathak, Sanjay Singh, Sangram Singh Patel, Ujjala Ghoshal, (2022). Bacterial coinfections in COVID: Prevalence, antibiotic sensitivity patterns and clinical outcomes from a tertiary institute of Northern India. Journal of Family Medicine Primary Care 11(8):4473.
Guangjie Wu, Jianhua Lu, Dong Liu, and Yan He. (2023). Characteristics and risk factors of secondary bacterial infections in COVID-19 patients. Antimicrobial Stewardship and Healthcare Epidemiology. 13;3(1).
Harnoor Singh Pruthi. (2022). When to Initiate Antifungal Treatment in COVID-19 Patients with Secondary Fungal Co-infection. Current Clinical Microbiology Reports. Springer Science and Business Media Deutschland GmbH.
Huan-Yi Wu, Peng-Hao Chang, Yu-Shan Huang, Chin-Siang Tsai, Kuan-Yu Chen, I-Fan Lin, (2023). Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan. Vol. 56, Journal of Microbiology, Immunology and Infection. Elsevier Ltd. p. 207–35.
Infection prevention and control guideline for coronavirus disease (2019) (COVID-19): Executive summary. WHO.
Ignacio Martin-Loeches, Marcus Schultz, Jean-Louis Vincent, Francisco Alvarez-Lerma, Lieuwe Bos, Jordi Solé-Violán, (2017). Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Medicine 43(1):48–58.
Jackson Musuuza, Lauren Watson, Vishala Parmasad, Nathan Putman-Buehler, Leslie Christensen, Nasia Safdar. (2021). Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and metaanalysis. PLoS One. 1;16(5 May).
Jennifer Farrell, Conan Zhao, Keiko Tarquinio, and Sam Brown. (2021). Causes and Consequences of COVID-19-Associated Bacterial Infections. Frontiers in Microbiology 20;12.
Jiyoung Lee, Euijin Chang, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sung-Han Kim, (2023). Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19. Journal of Korean Medical Science. 38(4).
Maddalena Peghin, Antonio Vena,Elena, Graziano, Daniele Roberto Giacobbe, Carlo Tascini, and Matteo Bassetti. (2022). Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19. Vol. 9, Therapeutic Advances in Infectious Disease. SAGE Publications Ltd.
Nanshan Chen, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 395(10223):507–13.
Narges Moradi, Niloufar Kazemi, Mehdi Ghaemi, and Bahman Mirzaei. (2021). Frequency and antimicrobial resistance pattern of bacterial isolates from patients with COVID-19 in two hospitals of Zanjan [Internet]. Vol. 13. Available from: http://ijm.tums.ac.ir
Sima Sadat Seyedjavadi, Parmida Bagheri, Mohammad Javad Nasiri, Mehdi Razzaghi-Abyaneh, and Mehdi Goudarzi. (2022). Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review. Vol. 13, Frontiers in Microbiology. Frontiers Media S.A.
Sara Mina, Hajar Yaakoub, Cedric Annweiler, Vincent Dubée, and Nicolas Papon. (2022). COVID-19 and Fungal infections: a double debacle. Vol. 24, Microbes and Infection. Elsevier Masson s.r.l.
Timothy Rawson, Luke Moore, Nina Zhu, Nishanty Ranganathan, Keira Skolimowska, Mark Gilchrist, Giovanni Satta, Graham Cooke, and Alison Holmes. (2020). Bacterial and Fungal Coinfection in Individuals with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescribing. Clinical Infectious Diseases. 71(9):2459-2468. doi: 10.1093/cid/ciaa530. PMID: 32358954; PMCID: PMC7197596.
Xi Chen, Binyou Liao, Lei Cheng, Xian Peng, Xin Xu, Yuqing Li, (2020). The microbial coinfection in COVID-19. Applied Microbiology and Biotechnology. 104: 7777–7785. Available from: https://doi.org/10.1007/s00253-020-10814-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 African Journal of Infectious Diseases (AJID)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright: Creative Commons Attribution CC BY This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.
